PRESS RELEASE published on 03/31/2026 at 08:00, 1 month 23 days ago METAVISIO - THOMSON COMPUTING : Renforcement de la direction financière pour accompagner la structuration du Groupe et son développement Nomination d'Aymeric Lhermitte en tant que Directeur Financier International chez METAVISIO - THOMSON Computing, renforçant les fondamentaux financiers du Groupe Développement Expertise Financière Directeur Financier METAVISIO - THOMSON Computing Aymeric Lhermitte
PRESS RELEASE published on 03/31/2026 at 07:50, 1 month 24 days ago Leifheit AG publishes annual report 2025 and launches next strategy phase with growth and efficiency program Leifheit AG publishes annual report 2025, confirms preliminary figures, and launches growth and efficiency program for 2026. Focus on brand relaunch, marketing, innovations, and cost reduction Annual Report Growth Leifheit AG Efficiency Program Strategy Phase
PRESS RELEASE published on 03/31/2026 at 07:45, 1 month 24 days ago ONWARD Medical Reports Full Year 2025 Financial and Operating Results, Highlighting Strong US Commercial Performance and Major Pipeline Milestones ONWARD Medical announces full year 2025 financial results with strong US commercial performance and major pipeline milestones. Company sells 117 ARC-EX Systems, reports EUR 5.4M in revenue, and raises EUR 50.8M in equity capital Financial Results ONWARD Medical Pipeline Milestones US Commercial Performance ARC-EX Systems
PRESS RELEASE published on 03/31/2026 at 07:31, 1 month 24 days ago adesso SE publishes 2025 consolidated financial statements: Sales increased to EUR 1.47 billion (+14%) / EBITDA improved by 30% to EUR 123.6 million / Earnings per share EUR 2.83 adesso SE reports strong 2025 financial performance with sales reaching EUR 1.47 billion (+14%) and EBITDA growing by 30% to EUR 123.6 million. Earnings per share at EUR 2.83 Sales Growth Earnings Per Share Adesso SE EBITDA Improvement 2025 Financial Statements
PRESS RELEASE published on 03/31/2026 at 07:30, 1 month 24 days ago Masterflex releases its 2025 Annual Report – record results achieved once again – new momentum from growth projects Masterflex SE releases record results in 2025 Annual Report with increased revenue and earnings. Equity ratio improves to 73.3%, debt reduced significantly. 2026 forecast: revenue expected between EUR 103.0 million and 108.0 million Revenue Earnings Masterflex SE Record Results 2025 Annual Report
PRESS RELEASE published on 03/31/2026 at 07:30, 1 month 24 days ago PAL Next AG: Business Performance in 2025 in Line with Plan PAL Next AG reports business performance in 2025 meeting expectations with improved equity ratio. Successful production exploitation and AI advancements noted Revenue Business Performance Equity Ratio 2025 PAL Next AG
PRESS RELEASE published on 03/31/2026 at 07:30, 1 month 24 days ago Nordex Group receives 42 MW order from Max Bögl in North Rhine-Westphalia, Germany Nordex Group secures 42 MW order for Peckelsheim wind farm in North Rhine-Westphalia, Germany from Max Bögl. Service agreement ensures turbine performance Nordex Group Wind Turbines Max Bögl 42 MW Order Peckelsheim
PRESS RELEASE published on 03/31/2026 at 07:30, 1 month 24 days ago Energiekontor AG: Energiekontor achieves solid Group earnings in the 2025 financial year and strengthens basis for further growth Energiekontor AG achieves solid Group earnings in 2025, with increased sales and dividend proposal doubled. Project pipeline grows, focusing on sustainable growth and profitability Sustainable Growth Dividend Proposal Project Pipeline Energiekontor AG Group Earnings
PRESS RELEASE published on 03/31/2026 at 07:30, 1 month 24 days ago Dermapharm Holding SE reports dip in revenue, rise in adjusted consolidated EBITDA and margin Dermapharm Holding SE reports dip in revenue but rise in adjusted consolidated EBITDA and margin for the 2025 financial year, with expectations of further growth in 2026 Adjusted EBITDA Dermapharm Holding SE Revenue Dip Financial Year 2025 Margin Rise
PRESS RELEASE published on 03/31/2026 at 07:30, 1 month 24 days ago Delignit AG stabilizes revenue in 2025, significantly increases profitability and plans to raise Dividend to 8 cents per share Delignit AG stabilizes revenue in 2025, significantly increases profitability, and plans to raise dividend. EBITDA rose over 36%, reaching €5.2 million. Equity ratio at record high of 78.8%. Moderate revenue growth expected for 2026 Profitability Increase Dividend Raise EBITDA Growth Delignit AG Revenue Stabilization
Published on 05/23/2026 at 19:45, 12 hours 5 minutes ago Golden Minerals Announces Closing of Equity Financing
Published on 05/23/2026 at 03:15, 1 day 4 hours ago UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Published on 05/23/2026 at 03:00, 1 day 4 hours ago Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Published on 05/23/2026 at 02:25, 1 day 5 hours ago Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Published on 05/23/2026 at 02:25, 1 day 5 hours ago Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
Published on 05/24/2026 at 05:55, 1 hour 55 minutes ago The 26th CIFIT to Open in Xiamen This September, Preceded by Successful Guangzhou Roadshow
Published on 05/24/2026 at 05:35, 2 hours 15 minutes ago CGTN: Xizang at 75: Development and culture create a 'miracle on Earth'
Published on 05/23/2026 at 16:30, 15 hours 20 minutes ago HiFS 2026: Upgrading Four Major Digital Finance Solutions to Accelerate Financial Institutions Toward Agentic Banking
Published on 05/23/2026 at 15:57, 15 hours 53 minutes ago EQS-Adhoc: Delivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
Published on 05/22/2026 at 22:05, 1 day 9 hours ago Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 19:35, 1 day 12 hours ago PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 1 day 13 hours ago Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 1 day 13 hours ago Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 1 day 18 hours ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 1 day 18 hours ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026